Related Experiment Video
Updated: May 22, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Combined antibacterial activity of phage lytic proteins holin and lysin from Streptococcus suis bacteriophage SMP
Yibo Shi1, Ning Li, Yaxian Yan
1Department of Animal Science, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai Key Laboratory of Veterinary Biotechnology, Shanghai, People's Republic of China.
Abstract:
Development of novel antibacterial agents is required to control infection with multidrug-resistant Streptococcus suis. HolSMP and LySMP, the holin and lysin of S. suis serotype 2 bacteriophage, named SMP, are responsible for lysis of host cells and release of progeny phage. HolSMP and LySMP expressed in Escherichia coli BL21(DE3) exerted efficient activity at 37 °C, pH 5.2, with addition of 0.8 % β-mercaptoethanol. Lytic spectra of purified HolSMP, LySMP or HolSMP + LySMP mixture were investigated. HolSMP, exhibiting a narrow lytic spectrum, was effective against Staphylococcus aureus and Bacillus subtilis, which were insensitive to LySMP. Moreover, HolSMP was identified as a promising antibacterial agent which was able to extend the spectrum of LySMP. The data suggest that combined use of holin and lysin could be a candidate strategy for resolution of drug resistance.
Insights
Novel antibacterial agents are crucial for combating multidrug-resistant Streptococcus suis. Researchers explored holin (HolSMP) and lysin (LySMP) from a S. suis bacteriophage, finding their combined use a promising strategy against resistant bacteria.
Area of Science:
- Microbiology
- Bacteriology
- Antimicrobial Research
Background:
- Multidrug-resistant Streptococcus suis poses a significant threat to public health.
- Novel antibacterial strategies are urgently needed to overcome antimicrobial resistance.
- Bacteriophage-derived proteins, holins and lysins, show potential as antimicrobial agents.
Purpose of the Study:
- To investigate the antibacterial activity of holin (HolSMP) and lysin (LySMP) from Streptococcus suis serotype 2 bacteriophage SMP.
- To evaluate the potential of these proteins, individually and in combination, as novel antibacterial agents.
- To explore their efficacy against multidrug-resistant bacterial strains.
Main Methods:
- HolSMP and LySMP were expressed in Escherichia coli BL21(DE3).
- Antibacterial activity was assessed at optimal conditions (37°C, pH 5.2, 0.8% β-mercaptoethanol).
- Lytic spectra of purified HolSMP, LySMP, and their mixture were determined against various bacterial species.
Main Results:
- Both HolSMP and LySMP demonstrated efficient lytic activity under tested conditions.
- HolSMP showed activity against Staphylococcus aureus and Bacillus subtilis, which were resistant to LySMP.
- The combination of HolSMP and LySMP broadened the lytic spectrum, enhancing overall antibacterial efficacy.
Conclusions:
- HolSMP and LySMP are effective antibacterial agents derived from S. suis bacteriophage SMP.
- HolSMP exhibits a distinct lytic spectrum and can enhance the activity of LySMP.
- The combined use of holin and lysin presents a viable strategy for developing novel treatments against drug-resistant bacteria.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Clinical Significance of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
DNA Bacteriophages

